Swara Baby Products: ₹1,000 crore IPO filed July 2026
Independent report content
| OFFER | Up to ₹1,000 crore: fresh issue up to ₹500 crore + offer for sale up to ₹500 crore (Brainbees Solutions up to ₹300 crore; Anadya Bon Merchari LLP up to ₹200 crore); optional pre-IPO placement up to ₹100 crore |
|---|---|
| STATUS | DRHP reported filed 2 Jul 2026; no SEBI approval, price band or dates found in the sources read |
| LEAD MANAGERS | JM Financial and Avendus Capital |
| FY26 | Revenue from operations ₹1,163.9 crore (+23.4%) · profit ₹95.58 crore (+18.5%) · margin about 8.2% |
| FY25 | Revenue ₹942.97 crore · profit ₹80.67 crore (8.6%) |
| MARKET POSITION (DRHP, BY VALUE, FY25) | 37% of baby-diaper and 36% of adult-diaper contract manufacturing; "India's largest contract manufacturer of disposable hygiene products" |
| CAPACITY | Four plants in Madhya Pradesh with 20 lines: about 2.66 billion baby diapers, 253 million adult diapers and period panties, 756 million sanitary napkins and panty liners a year |
| CUSTOMERS / BRANDS | Brainbees Solutions (FirstCry), Piramal Pharma, Himalaya Wellness; own brands Cuddles and Shield |
| THE ACCESS POINT Swara Baby Products is unlisted. The IPO is the route once SEBI clears it and a price band is set. Public lists on three IPO sites did not show it among upcoming issues in the sources read, so the status should be checked against SEBI filings. |
|---|
Executive decision summary
| THE BOTTOM LINE Swara Baby Products makes baby and adult diapers, sanitary napkins and panty liners, mostly for other companies' brands, and says it is India's largest contract manufacturer of disposable hygiene products by value (FY25), with 37% of baby-diaper contract manufacturing. FY26 revenue was ₹1,163.9 crore (up 23.4%) and profit ₹95.58 crore (up 18.5%), a margin of about 8%. The ₹1,000 crore offer is half fresh issue and half sale; the sellers are Brainbees Solutions (which also owns FirstCry and is a customer) and Anadya Bon Merchari LLP. A contract manufacturer has volume and cost advantages but little pricing power or brand: the questions are customer concentration, the share of own brands and how much of the new money is spent on a fresh plant and debt repayment, none of which carries amounts in the sources read. |
|---|
| WHICH INVESTOR Fits you IF you want a scale manufacturer in a consumer category with structural volume growth and an asset base that supports brand-owner outsourcing. Look elsewhere IF you want brand pricing power or high margins: contract manufacturing earns thin margins and depends on a few customers. |
|---|
| COMFORT FIT Swara = the factory behind brands: it makes diapers that carry other companies' names, plus Cuddles and Shield of its own. Brainbees (FirstCry) = both a customer and a selling shareholder, so its interests are on both sides. Contract manufacturing = steady volume, low margin and high dependence on a few buyers. |
|---|
| THE RUPEIA NUMBER 37%. Share of baby-diaper contract manufacturing by value in FY25 (company-reported, DRHP). |
|---|
1 CLAIM REGISTER: EVIDENCE GRADING
A = government or regulator record. B = statutory filing. C = independent press. D = company announcement.
| Claim | Source | Grade | Rupeia assessment |
|---|---|---|---|
| Offer ₹1,000 crore: fresh ≤₹500 crore + OFS ≤₹500 crore; sellers Brainbees ≤₹300 crore and Anadya Bon Merchari ≤₹200 crore; pre-IPO ≤₹100 crore | Business Today (2 Jul 2026) | B | Single article read. |
| Lead managers JM Financial and Avendus Capital | Business Today | B | Registrar not found. |
| Revenue ₹1,163.9 / 942.97 crore; profit ₹95.58 / 80.67 crore (FY26 / FY25) | Business Today, from the DRHP | B | Consolidated or standalone not stated; FY24 not found. |
| 37% baby-diaper and 36% adult-diaper contract manufacturing share by value, FY25 | Business Today (DRHP) | C | Company-reported, industry-report basis. |
| Four plants, 20 lines; capacity 2.66 billion baby diapers, 253 million adult diapers/period panties, 756 million napkins/liners | Business Today | B/C | Reported. |
| Founded 2018; acquired K.A. Enterprises Hygiene in December 2025 | Business Today | B/C | Price not given. |
| Customers Brainbees Solutions, Piramal Pharma, Himalaya Wellness | Business Today | B/C | Shares of revenue not given. |
| No SEBI observation, RHP or listing found | Chittorgarh, Kotak Neo, Groww list pages | C | Lists may lag; verify with SEBI. |
2 COMPANY OVERVIEW & FOUNDING STORY
Swara Baby Products was founded in 2018 and makes baby diapers, adult diapers, sanitary napkins and panty liners. It manufactures for other brands and sells its own Cuddles and Shield brands. It operates four manufacturing facilities with 20 production lines in Madhya Pradesh and acquired K.A. Enterprises Hygiene in December 2025.
Customers named in the DRHP include Brainbees Solutions (the parent of the baby-products retailer FirstCry), Piramal Pharma and Himalaya Wellness. Brainbees is also a selling shareholder in the OFS, which links one of its largest customers to the exit.
The fresh issue is intended to fund a new manufacturing facility in Madhya Pradesh, repay borrowings, invest in subsidiaries to repay their debt, make acquisitions and meet general purposes. Amounts per object, promoters' holdings and headquarters were not found in the sources read.
3 TIMELINE
| Date | Event |
|---|---|
| 2018 | Founded |
| FY25 | Revenue ₹942.97 crore; profit ₹80.67 crore; largest contract manufacturer of disposable hygiene products by value (DRHP claim) |
| Dec 2025 | Acquires K.A. Enterprises Hygiene |
| FY26 | Revenue ₹1,163.9 crore (+23.4%); profit ₹95.58 crore (+18.5%) |
| 2 Jul 2026 | DRHP filing reported (₹1,000 crore) |
| Nov 2026 | No SEBI observation or price band found |
4 OFFER STRUCTURE AND SELLERS
| Item | Detail | Figure | Comment |
|---|---|---|---|
| Fresh issue | New shares | Up to ₹500 crore | Plant, debt repayment, acquisitions, general purposes |
| Offer for sale | Selling shareholders | Up to ₹500 crore | Brainbees ≤₹300 crore; Anadya Bon Merchari ≤₹200 crore |
| Pre-IPO placement | Optional | Up to ₹100 crore | Whether it reduces the fresh issue is not stated |
| Lead managers | BRLMs | JM Financial, Avendus Capital | — |
| Price band, dates, registrar | Not announced | — | — |
Brainbees is selling 60% of the OFS (₹300 crore of ₹500 crore) and the offer is split evenly between company money and seller money.
| RUPEIA CALCULATION Half the offer (₹500 crore) goes to the sellers and half to the company. At FY26 profit of ₹95.58 crore, ₹500 crore of fresh money is 5.2 times annual profit, so the use of proceeds is material. Without amounts for the plant and debt repayment, the effect on leverage cannot be computed; the RHP should show them. |
|---|
5 FINANCIAL FORENSICS: GROWTH WITH A THIN MARGIN
| ₹ crore | FY25 | FY26 | Change |
|---|---|---|---|
| Revenue from operations | 942.97 | 1,163.9 | +23.4% |
| Net profit | 80.67 | 95.58 | +18.5% |
| PAT margin (Rupeia) | 8.6% | 8.2% | −0.3 pt |
| EBITDA, debt, cash flow | Not found | Not found | — |
| FY24 revenue and profit | Not found | — | — |
Revenue grew faster than profit, so margin slipped slightly. The acquisition of K.A. Enterprises Hygiene in December 2025 will add to FY26 and FY27 revenue; whether any of the 23.4% growth is acquired is not stated. EBITDA and net debt are missing, so the true leverage and return on capital cannot be assessed.
| RUPEIA CALCULATION Margin sensitivity. At FY26 revenue of ₹1,163.9 crore, each 1 percentage point of net margin is about ₹11.6 crore of profit. A fall of the margin from 8.2% to 6.2% would take profit from ₹95.58 crore to about ₹72.2 crore, a drop of 24%. Contract manufacturers are exposed to raw-material costs (fluff pulp, super-absorbent polymer, non-woven fabric), where price changes pass through to customers with a lag. This is a Rupeia illustration, not a forecast. |
|---|
6 BUSINESS MODEL & UNIT ECONOMICS
Swara earns by manufacturing disposable hygiene products for others and for its own brands.
| Line | How it earns | Pressure point |
|---|---|---|
| Baby diapers (contract) | 37% of contract manufacturing by value; 2.66 billion pieces of capacity | Brand owners can switch or insource |
| Adult diapers (contract) | 36% share; 253 million pieces (with period panties) | Smaller category; institutional buyers |
| Sanitary napkins and panty liners | 756 million pieces of capacity | Price-sensitive; competition from established brands |
| Own brands (Cuddles, Shield) | Higher margin if scaled | Needs marketing and distribution |
| Acquired capacity (K.A. Enterprises Hygiene) | Added in December 2025 | Integration; price not disclosed |
Contract manufacturing converts materials into finished goods for brand owners at a negotiated price per unit. High utilisation across 20 lines and long-term supply agreements are what protect margin.
7 MARKET & COMPETITIVE ANALYSIS
| Peer | Status | Position |
|---|---|---|
| Procter & Gamble Hygiene and Health Care | Listed | Pampers and Whisper brand owner; Rupeia context, no figures sourced |
| Kimberly-Clark, Unicharm | Global | Huggies and MamyPoko brand owners |
| Himalaya, FirstCry (Brainbees) | Private / listed | Brand owners and customers |
| Other Indian hygiene contract makers | Private | Not named in the sources read |
The sources do not give listed peer multiples for contract manufacturers. The comparison set is brand owners (higher margin, advertising-heavy) and other contract makers (lower margin); the correct benchmark is closer to the latter.
8 1. CONTRACT MANUFACTURING VERSUS OWNING A BRAND
A brand owner such as FirstCry decides price, marketing and shelf placement, and pays a manufacturer a per-unit price. The manufacturer wins scale and steady volume but gives up brand value. Swara's own brands, Cuddles and Shield, are the route to higher margins, but they compete with national brands that spend heavily on advertising.
| Feature | Contract manufacturer | Brand owner |
|---|---|---|
| Pricing power | Low; negotiated per unit | Higher; set at shelf |
| Marketing spend | Low | High |
| Customer concentration | Often high | Spread across consumers |
| Capital intensity | High (lines, plants) | Lower if outsourcing |
| Typical margin | Single-digit to low-teens net | Higher but more volatile |
General description by Rupeia; Swara's margin is about 8%.
9 2. CAPACITY AND UTILISATION
| Product | Annual capacity | Source |
|---|---|---|
| Baby diapers | ~2.66 billion pieces | Business Today (DRHP) |
| Adult diapers and period panties | ~253 million pieces | Business Today |
| Sanitary napkins and panty liners | ~756 million pieces | Business Today |
| Plants / lines | Four facilities, 20 lines, Madhya Pradesh | Business Today |
| Capacity utilisation | Not found | — |
| New plant (fresh issue) | Madhya Pradesh; cost and capacity not found | Business Today |
| RUPEIA CALCULATION Rupeia calculation: if all capacity were baby diapers, 2.66 billion pieces over 20 lines is about 133 million pieces a line a year, but lines are not interchangeable and capacity is shared across products. At FY26 revenue of ₹1,163.9 crore, revenue per line is about ₹58 crore (₹1,163.9 crore ÷ 20). Both figures are crude averages, not company data. |
|---|
10 3. CUSTOMERS AND RELATED-PARTY ANGLE
Brainbees Solutions: customer and selling shareholder (≤₹300 crore of the OFS). The RHP should show its share of revenue and the pricing terms.
Piramal Pharma and Himalaya Wellness: named customers; shares of revenue not given.
Concentration test: the top five customers' share of revenue and the contract terms (tenor, price pass-through, minimum volume) are the key items.
Anadya Bon Merchari LLP: a selling shareholder; identity and holding not given in the sources read.
When a seller in the OFS is also a leading customer, the market will want to see that price and volume commitments survive the exit.
11 4. USE OF THE FRESH ISSUE
| Object | Amount | What it means |
|---|---|---|
| New plant, Madhya Pradesh | Not shown | Capacity expansion; depends on utilisation |
| Repay borrowings | Not shown | Reduces interest cost; leverage unknown |
| Investment in subsidiaries for debt repayment | Not shown | Debt may sit in subsidiaries |
| Inorganic acquisitions | Not shown | Further deals like K.A. Enterprises |
| General corporate purposes | Not shown | Residual |
None of the object amounts appeared in the sources read. A fresh issue of up to ₹500 crore against FY26 profit of ₹95.58 crore is large enough that the split between growth and debt repayment decides how much of the proceeds improves returns.
12 5. VALUATION GRID
| Post-issue value (₹ crore) | P/E on ₹95.58 cr | x revenue ₹1,163.9 cr | ₹1,000 cr as % of equity |
|---|---|---|---|
| 2,000 | 20.9x | 1.7x | 50.0% |
| 3,000 | 31.4x | 2.6x | 33.3% |
| 4,000 | 41.9x | 3.4x | 25.0% |
| 5,000 | 52.3x | 4.3x | 20.0% |
No valuation has been published. Rupeia arithmetic.
| RUPEIA CALCULATION Rupeia calculation: at 31x earnings (₹3,000 crore) the offer would be a third of the company, an unusually large float for a mainboard issue. At that value the fresh issue of ₹500 crore is 16.7% and the OFS 16.7% of post-issue equity. A contract manufacturer with an 8% net margin would normally be valued below a brand owner on revenue (2.6x here), so the grid shows where the multiple would feel stretched. |
|---|
13 6. INDUSTRY CONTEXT (WITHOUT FIGURES THE SOURCES DID NOT GIVE)
Disposable hygiene products in India have low penetration relative to developed markets and are sold through general trade, modern retail and e-commerce. The sources read give no market-size or growth figures for diapers or napkins; the DRHP's industry report would. What the sources do show is a manufacturer that has taken about a third of contract manufacturing in two categories, which implies that brand owners are outsourcing production at scale.
14 7. RISK MAP
| Risk | Mechanism | Where to look in the RHP |
|---|---|---|
| Customer concentration | A few brand owners dominate sales | Top customer share |
| Raw-material costs | Pulp, polymer and non-woven prices | Material cost share and pass-through terms |
| Thin margin | Contract pricing leaves ~8% net margin | Margin by product and customer |
| Related-party sales | Brainbees is customer and seller | Related-party note |
| Integration risk | K.A. Enterprises Hygiene acquired December 2025 | Contribution and price |
| Capacity overbuild | New plant adds supply if demand lags | Utilisation by plant |
| Regulatory and quality | Hygiene and baby-care product standards | Approvals and recalls |
15 8. QUESTIONS FOR THE RED HERRING PROSPECTUS
Revenue by product, customer and own-brand versus contract for FY24–FY26.
EBITDA, net debt, interest cost and cash flow.
Amounts for each object of the fresh issue.
Promoters, holdings and the identity of Anadya Bon Merchari LLP.
Contract terms with Brainbees, Piramal Pharma and Himalaya Wellness.
Capacity utilisation and the cost and size of the new plant.
Purchase price and contribution of K.A. Enterprises Hygiene.
SEBI observation date and validity.
16 9. GLOSSARY
| Term | Meaning |
|---|---|
| Contract manufacturing | Making goods for another company's brand |
| Panty liner / period panty | Hygiene products in the sanitary-care range |
| Fluff pulp / SAP / non-woven | Main raw materials in diapers |
| OFS / fresh issue | Sale by existing holders versus new shares |
| Pre-IPO placement | Private placement before the public offer |
17 VALUATION SCENARIOS
| Scenario | Post-issue value (₹ crore) | P/E on FY26 | What must be true |
|---|---|---|---|
| Bear | 2,000 | 20.9x | Thin margin and concentration dominate |
| Base | 3,000 | 31.4x | Steady 20% growth and clear use of proceeds |
| Bull | 4,500 | 47.1x | Own brands scale and margin rises |
Rupeia scenarios; no valuation has been published.
18 SCENARIO ANALYSIS
| Scenario | Probability | What happens |
|---|---|---|
| Bull | 20% | SEBI clears the issue; own brands lift margin; IPO at 40x+ |
| Base | 45% | IPO at 25–35x earnings; margins hold near 8% |
| Bear | 35% | Approval delay or weak markets; concentration concerns reduce the price |
19 RISK ANALYSIS: RED FLAG LEDGER & KILL CONDITIONS
| Risk | Severity | Kill condition |
|---|---|---|
| Customer concentration and related-party sales | High | Top customer share; Brainbees terms |
| Thin margin and raw-material swings | High | Net margin below 7% |
| SEBI status unconfirmed | Medium | Observation letter and validity |
| Capacity expansion execution | Medium | New plant cost and utilisation |
| Acquisition integration | Medium | K.A. Enterprises contribution |
| Missing data (EBITDA, debt, FY24) | Medium | RHP disclosure |
20 INVESTOR CLASS ANALYSIS
HNIs and family offices
Wait for the RHP. The decisive items are customer concentration, Brainbees' contract terms and the use-of-funds split; a thin-margin contract manufacturer should be priced below a brand owner.
Institutions
Institutions will test customer stickiness, raw-material pass-through and the case for the new plant.
NRIs
NRIs can hold unlisted Indian shares under FEMA pricing and reporting rules; repatriation depends on the account route used.
21 THE EARLY SIGNAL: EVENTS TO WATCH
| When | Event |
|---|---|
| Q4 2026–2027 | SEBI observations (if not already received); RHP |
| Optional | Pre-IPO placement up to ₹100 crore |
| Post-listing | First quarterly results |
22 RUPEIA FINAL INDEPENDENT VIEW
Swara has scale, share and growth in a category brands are outsourcing. A margin of about 8%, an unconfirmed regulatory status and a customer that is also a seller are the reasons to wait for the prospectus.
| THE RUPEIA NUMBER 37%. Share of baby-diaper contract manufacturing by value in FY25 (company-reported, DRHP). |
|---|
| RUPEIA VERDICT Scale manufacturer with thin margin. Wait for the RHP. |
|---|
Frequently asked questions
How big is Swara Baby Products' IPO?
Up to ₹1,000 crore: ₹500 crore fresh and ₹500 crore offer for sale.
Who is selling?
Brainbees Solutions (up to ₹300 crore) and Anadya Bon Merchari LLP (up to ₹200 crore).
What are Swara's revenue and profit?
FY26 revenue ₹1,163.9 crore and profit ₹95.58 crore, up 23.4% and 18.5%.
What does Swara make?
Baby and adult diapers, sanitary napkins and panty liners, mostly as a contract manufacturer, plus the Cuddles and Shield brands.
Has SEBI approved the IPO?
The sources read show a DRHP filing in July 2026 but no observation letter.
Source log
Business Today: Swara Baby, TMC Transformers, Ratnadeep Retail file DRHPs
Chittorgarh: upcoming IPOs with DRHP filed
Kotak Neo: upcoming IPOs
Groww: upcoming IPOs
| DISCLAIMER This report is independent research by Rupeia Investments Co. built only from public sources as of the date shown. It is not an offer, solicitation or investment advice, and it is not a recommendation to buy or sell any security. Private-company figures are drawn from filings and media reports and may be revised. Unlisted and private-market investments are illiquid and carry a risk of total loss. Investors should take independent advice. |
|---|
